Company Description
Houlihan Lokey, Inc., an investment banking company, provides merger and acquisition (M&A), capital market, financial restructurings and liability management, and financial and valuation advisory services worldwide.
The company operates in three segments: Corporate Finance (CF), Financial Restructuring (FR), and Financial and Valuation Advisory (FVA).
The CF segment offers general financial advisory services; and advises public and private institutions, including financial sponsors on buy-side and sell-side M&A transactions, debt and equity financings in both the private and public markets, and other corporate finance transactions.
The FR segment advises debtors, creditors, and other parties-in-interest related to recapitalization/deleveraging transactions.
This segment also provides a range of advisory services, such as structuring, negotiation, and confirmation of plans of reorganization; structuring and analysis of exchange offers; liability management transactions; corporate viability assessment; dispute resolution and expert testimony; and procuring debtor-in-possession financing.
The FVA segment provides valuation services to companies; debt and equity interests comprising illiquid investments; and other assets and liabilities.
This segment also offers fairness opinions in connection with mergers and acquisitions and other transactions; solvency opinions in connection with corporate spin-offs and dividend recapitalizations; other types of financial opinions; and diligence, tax, transaction accounting, and other financial advisory services, as well as dispute resolution services.
It serves corporations, financial sponsors, and government agencies. Houlihan Lokey, Inc. was incorporated in 1972 and is headquartered in Los Angeles, California.
| Country | United States |
| Founded | 1972 |
| IPO Date | Aug 13, 2015 |
| Industry | Capital Markets |
| Sector | Financials |
| Employees | 2,800 |
| CEO | Scott Adelson |
Contact Details
Address: 10250 Constellation Boulevard, 5th Floor Los Angeles, California 90067 United States | |
| Phone | 310 553 8871 |
| Website | hl.com |
Stock Details
| Ticker Symbol | HLI |
| Exchange | NYSE |
| Stock Type | Common Stock |
| Share Class | Class A Shares |
| Fiscal Year | April - March |
| Reporting Currency | USD |
| CIK Code | 0001302215 |
| CUSIP Number | 441593100 |
| ISIN Number | US4415931009 |
| Employer ID | 95-2770395 |
| SIC Code | 6282 |
Key Executives
| Name | Position |
|---|---|
| Craig E. Tessimond | Managing Director |
| Nana Kyei | Managing Director of Technology Group |
| Jacques Cornet | Investor Relations Professional |
| Charles A. Yamarone | Chief Corporate Governance and Compliance Officer |
| Jeffrey Werbalowsky | Senior Managing Director |
| James Francis Lavelle | MD and Head of Corporate Coverage and Industrials |
| Matthew R. Niemann | Managing Director |
| Jay Novak | MD and Head of The Consumer, Food and Retail Group |
| Ranon Kent | MD and Global Head of Business Services Group |
| John George Mavredakis | Global Head of the Financial Sponsors Group and Senior MD |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jul 31, 2026 | 10-Q | Quarterly Report |
| Jul 30, 2026 | 8-K | Current Report |
| Jul 24, 2026 | ARS | Filing |
| Jul 24, 2026 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Jul 24, 2026 | DEF 14A | Other definitive proxy statements |
| May 22, 2026 | 10-K | Annual Report |
| May 21, 2026 | 144 | Filing |
| May 14, 2026 | SCHEDULE 13G/A | Filing |
| May 7, 2026 | 8-K | Current Report |
| Apr 30, 2026 | SCHEDULE 13G | Filing |